The role of platelets in non-alcoholic fatty liver disease: from pathophysiology to therapeutics

N Malladi, MJ Alam, SK Maulik, SK Banerjee - Prostaglandins & other lipid …, 2023 - Elsevier
Platelets are one of the key mediators in thrombosis as well as in the progression of many
diseases. An increase in platelet activation and a decrease in platelet count is associated …

Overview of cellular and soluble mediators in systemic inflammation associated with non-alcoholic fatty liver disease

P Marques, V Francisco, L Martínez-Arenas… - International Journal of …, 2023 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is currently the most prevalent chronic liver
disease in Western countries, affecting approximately 25% of the adult population. This …

Diagnostic sensitivity of NLR and PLR in early diagnosis of gastric cancer

T Fang, Y Wang, X Yin, Z Zhai, Y Zhang… - Journal of …, 2020 - Wiley Online Library
The neutrophil‐lymphocyte ratio (NLR) and the platelet‐lymphocyte ratio (PLR) are markers
of systemic inflammation. However, there is little evidence of the value of inflammation in the …

Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID‐19): a multicenter, cross‐sectional study

J Peng, D Qi, G Yuan, X Deng, Y Mei… - Journal of clinical …, 2020 - Wiley Online Library
Background To determine the diagnostic value of hematologic markers for coronavirus
disease 2019 (COVID‐19) and explore their relationship with disease severity. Methods …

High neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio are associated with poor survival in patients with hemodialysis

J Zhang, X Lu, S Wang, H Li - BioMed Research International, 2021 - Wiley Online Library
Background. The neutrophil‐to‐lymphocyte ratio (NLR) and platelet‐to‐lymphocyte ratio
(PLR) are markers for systemic inflammation condition. Although NLR has emerged as a risk …

Simple parameters from complete blood count predict in‐hospital mortality in COVID‐19

M Bellan, D Azzolina, E Hayden, G Gaidano… - Disease …, 2021 - Wiley Online Library
Introduction. The clinical course of Coronavirus Disease 2019 (COVID‐19) is highly
heterogenous, ranging from asymptomatic to fatal forms. The identification of clinical and …

Distribution and reference interval establishment of neutral‐to‐lymphocyte ratio (NLR), lymphocyte‐to‐monocyte ratio (LMR), and platelet‐to‐lymphocyte ratio (PLR) in …

J Wang, F Zhang, F Jiang, L Hu… - Journal of Clinical …, 2021 - Wiley Online Library
Background Neutral‐to‐lymphocyte ratio (NLR), lymphocyte‐to‐monocyte ratio (LMR), and
platelet‐to‐lymphocyte ratio (PLR) are associated with coronavirus disease 2019 (COVID …

Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease

N Salva-Pastor, NC Chavez-Tapia, M Uribe… - The Journal of Steroid …, 2019 - Elsevier
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among
reproductive-age women. Patients with non-alcoholic fatty liver disease (NAFLD) often suffer …

Preoperative neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio, and CEA as the potential prognostic biomarkers for colorectal cancer

F Ming-Sheng, D Mei-Ling, C Xun-Quan… - Canadian Journal of …, 2022 - Wiley Online Library
Background. This study was to evaluate the prognostic value of the preoperative neutrophil‐
to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), and carcinoembryonic …

Early changes in laboratory tests predict liver function damage in patients with moderate coronavirus disease 2019: a retrospective multicenter study

Y Wang, D Gao, X Li, P Xu, Q Zhou, J Yin, J Xu - BMC gastroenterology, 2022 - Springer
Background Most patients with coronavirus disease 2019 demonstrate liver function
damage. In this study, the laboratory test data of patients with moderate coronavirus disease …